Quebec COVID-19 vaccine manufacturer Medicago to cease operations
Medicago's parent company has announced that the Quebec City-based biopharmaceutical company, which developed a vaccine against COVID-19, will cease operations.
In a Thursday statement, the Japanese group Mitsubishi Chemical Corporation said it decided to stop commercializing the Covifenz vaccine, licensed by Health Canada in February 2022 for adults aged 18 to 64.
"Since [the approval in Canada], the company had been preparing for the transition to commercial production," the group said. "However, in light of the significant changes in the COVID-19 vaccine landscape since the authorization of Covifenz and following a comprehensive analysis of current global demand, the economic environment with respect to COVID-19 vaccines, and the challenges Medicago faces in transitioning to commercial production, the group has decided not to pursue commercialization."
Mitsubishi Chemical also deemed it "not viable" to continue to invest in the commercialization of Medicago's development products.
"[The group] has therefore chosen to terminate all of its business with Medicago and conduct an orderly dissolution of its commercial business and operations," it says.
Last May, the World Health Organization (WHO) rejected the Quebec biopharmaceutical's COVID-19 vaccine, which uses plants in its manufacturing process.
The reason for the rejection was the presence of tobacco company Philip Morris as a minority shareholder in the company, a decision linked to a policy of the UN agency adopted in 2005.
This report by The Canadian Press was first published in French by The Canadian Press on Jan. 2, 2023.
CTVNews.ca Top Stories
Budget 2023 prioritizes pocketbook help and clean economy, deficit projected at $40.1B
In the 2023 federal budget, the government is unveiling continued deficit spending targeted at Canadians' pocketbooks, public health care and the clean economy.

Freeland's green economy spending aimed at competing with U.S. Inflation Reduction Act
Finance Minister Chrystia Freeland says clean energy and green technology spending may not have been the big-ticket items of the 2023 federal budget if it weren’t for the need to compete with infrastructure spending in the United States.
Federal government capping excise tax on alcohol after outcry
The increase in excise duties on all alcoholic products is being temporarily capped at two per cent starting next month instead of a planned 6.3 per cent increase.
opinion | The gun control debate in America has been silenced
In the wake of another deadly mass shooting in America, that saw children as young as nine years old shot and killed, the gun control debate is going nowhere, writes CTV News political analyst Eric Ham.
Was Stonehenge a giant calendar? New research suggests maybe not
Stonehenge's purpose has long been a mystery, with some researchers proposing that it may have been an ancient solar calendar. But now, new analysis suggests the calendar theory is unsubstantiated.
Kids would rather learn from smart robots than less-smart humans: new study
A new study published by Canadian researchers suggests that kindergarten-age children would rather be taught by a competent robot than an incompetent human.
‘Using waste material makes sense’: Mysterious artist Junko turns trash into giant sculptures
A mysterious, Montreal-based street artist named Junko is generating buzz in Metro Vancouver with futuristic, bug-like sculptures made from old car parts, scrap metal and tossed out shoes.
New research finds subtle brain changes in pre-symptomatic Alzheimer’s patients
A new peer-reviewed study from the Medical University of South Carolina report in Brain Connectivity has found individualized brain fingerprints which can help diagnose early Alzheimer's disease.
Hamilton family raising awareness about Strep A after sudden death of toddler
A Hamilton, Ont., family is hoping to raise awareness about Strep A after the tragic death of their two-year-old.